Proteome Sciences (LSE:PRM) EBIT per Share : £-0.01 (TTM As of Jun. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Proteome Sciences EBIT per Share?

Proteome Sciences's EBIT per Share for the six months ended in Jun. 2024 was £-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 was £-0.01.

During the past 12 months, the average EBIT per Share Growth Rate of Proteome Sciences was -375.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Proteome Sciences's EBIT per Share or its related term are showing as below:

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Proteome Sciences was 81.70% per year. The lowest was -55.90% per year. And the median was 10.55% per year.

LSE:PRM's 3-Year EBIT Growth Rate is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 1.05
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Proteome Sciences's EBIT for the six months ended in Jun. 2024 was £-1.71 Mil.

Proteome Sciences EBIT per Share Historical Data

The historical data trend for Proteome Sciences's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteome Sciences EBIT per Share Chart

Proteome Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.01

-0.01

Proteome Sciences Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBIT per Share	Get a 7-Day Free Trial															-	0.01	-	-0.01	-0.01

Proteome Sciences EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Proteome Sciences's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-1.621	/	311.222
=	-0.01

Proteome Sciences's EBIT per Share for the quarter that ended in Jun. 2024 is calculated as

	EBIT per Share		(Q: Jun. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-1.706	/	308.629
=	-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.01

Proteome Sciences (LSE:PRM) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Proteome Sciences EBIT per Share Related Terms

Thank you for viewing the detailed overview of Proteome Sciences's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Proteome Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Proteome Sciences PLC (LSE:PRM) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

PMSNF:USA PRM.GB:UK

Address

Downside Bridge Road, Coveham House, Cobham, Surrey, GBR, KT11 3EP

Website

https://www.proteomics.com

Proteome Sciences PLC is protein biomarker research and development. provider of contract research services for the identification, validation and application of protein biomarkers. Its only reportable segment is the sale of goods and biomarker services. It generates maximum revenue from the TMT product and end customer sales-based royalties. Geographically, it has a presence in the United States, the United Kingdom, the European Union, and Other.